Glimepiride (Standard)
Based on 1 Customer Validation
Glimepiride (Standard) is the analytical standard of Glimepiride. This product is intended for research and analytical applications. Glimepiride (Glimperide) is a medium-to-long acting sulfonylurea anti-diabetic compound with an ED50 of 182 μg/kg.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza : 99.74%
- No. CAS: 93479-97-1
- Fòrmula: C₂₄H₃₄N₄O₅S
- Peso molecular:490.62
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureza y Documentación
-
Help & FAQs
-
HY-15206
GlibenclamideKATP Inhibitor -
HY-B0254R
Glipizide (Standard)Anti-diabetic Agent -
HY-B0104
GlimepirideAnti-diabetic Agent -
HY-15209R
Repaglinide (Standard)Insulin Secretagogue -
HY-10284
LinagliptinDPP-4 Inhibitor -
HY-14291
VildagliptinDPP-IV Inhibitor -
HY-B0753R
Gliclazide (Standard) -
HY-13233A
Talabostat mesylateDipeptidyl Peptidase Inhibitor -
HY-10285
SaxagliptinDPP-4 Inhibitor -
HY-A0023A
AlogliptinDPP-4 Inhibitor -
HY-15209
RepaglinideInsulin Secretagogue -
HY-15408
TrelagliptinDPP-4 Inhibitor
Product Information
Information
Aplicación
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
No. CAS 93479-97-1
-
Appearance Solid
-
Peso molecular 490.62
-
Fòrmula C₂₄H₃₄N₄O₅S
-
Color White to off-white
-
SMILES
O=C(N1C(C(CC)=C(C)C1)=O)NCCC2=CC=C(S(=O)(NC(N[C@H]3CC[C@H](C)CC3)=O)=O)C=C2
-
Synonyms
Glimperide (Standard); HOE-490 (Standard)
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
-
SDS (644 KB)
- English - EN (644 KB)
- Français - FR (644 KB)
- Deutsch - DE (644 KB)
- Norwegian - NO (644 KB)
- Español - ES (644 KB)
- Swedish - SV (644 KB)
- Italian - IT (644 KB)
- Korean - KR (644 KB)
- Portuguese - PT (644 KB)
-
Instrucciones de manejo (2659 KB)
Referencias
[1]. Geisen, K., Special pharmacology of the new sulfonylurea glimepiride. Arzneimittelforschung, 1988. 38(8): p. 1120-30. [Content Brief]
[2]. Liu, F., et al., Glimepiride attenuates Abeta production via suppressing BACE1 activity in cortical neurons. Neurosci Lett, 2013. 557 Pt B: p. 90-4. [Content Brief]
[3]. Basit, A., M. Riaz, and A. Fawwad, Glimepiride: evidence-based facts, trends, and observations (GIFTS). [corrected]. Vasc Health Risk Manag, 2012. 8: p. 463-72. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Glimepiride (Standard) Related Classifications
HY-B0104R Related Classifications
Powered by Bioz